| CAS ID: | 990-73-8 |
| Molecular Formula: | C28H36N2O8 |
| Molecular Weight: | 336.5 g/mol |
| Monoisotopic Mass: | 336.2202 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | MCN-JR-4263-49 | SUBLIMAZE | SUBLIMAZE PRESERVATIVE FREE | ABSTRAL | LAZANDA | ACTIQ | FENTANYL | R-4263 | FENTANYL CITRATE | FENTORA | FENTANYL CITRATE PRESERVATIVE FREE | ONSOLIS | THALAMONAL |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C22H28N2O.C6H8O7/c1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-12,21H,2,13-18H2,1H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12) | See All |
| InChI Key: | IVLVTNPOHDFFCJ-UHFFFAOYSA-N | |
| Smiles: | CCC(=O)N(C1CCN(CCc2ccccc2)CC1)c3ccccc3.OC(=O)CC(O)(CC(=O)O)C(=O)O | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT03018756 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 3 | Status | Recruiting |
| First Received | January 12, 2017 | Last Verified | September 25, 2018 |
| Sponsor | Queen's University | ||